Ultrafast magnetic resonance imaging protocols in stroke

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 76, Issue 7, 2005, Pages 905-

  Ringelstein, E B ^a  

^a UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HEMOSIDERIN;

BRAIN HEMORRHAGE; CEREBROVASCULAR DISEASE; CLINICAL PROTOCOL; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION WEIGHTED IMAGING; EDITORIAL; FIBRINOLYTIC THERAPY; HUMAN; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; PRIORITY JOURNAL; RISK; STROKE;

CEREBRAL HEMORRHAGE; CEREBRAL INFARCTION; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; IMAGE ENHANCEMENT; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; PATIENT SELECTION; RECURRENCE; THROMBOLYTIC THERAPY; TIME FACTORS;

EID: 21344443465     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.2004.060871     Document Type: Editorial

References (4)

1. NINDS (National Institute of Neurological Disorders and Stroke rt-PA) Stroke Study-Group. Tissue Plasminogen Activator for Acute Ischaemic Stroke. In: N Engl J Med 1995;333:1581-7.
2. Röther J, Schellinger PD, Gass A, for the Kompetenznetzwerk Schlaganfoll Study Group, et al. Effect of Intravenous Thrombloysis on MRI Parameters and Functional Outcome in Acute Stroke <6 Hours. Stroke 2002;33:2438-45.
3. Ringelstein EB, Biniek R, Weiller C, et al. Type and extent of hemispheric brain infarctions and clinical outcome in early and delayed middle cerebral artery recanalization. Neurology 1992;42:289-98.
4. Mayer SA, Brun NC, Broderick J, et al. Europe/AustralAsia NovoSeven ICH Trial Investigators. Safety and feasibility of recombinant factor VIIa for acute intracerebral hemorrhage. Stroke 2005;36:74-9.